Recap: F N B Q1 Earnings

F N B (NYSE:FNB) reported its Q1 earnings results on Wednesday, April 19, 2023 at 04:30 PM. Here’s…

F N B (NYSE:FNB) reported its Q1 earnings results on Wednesday, April 19, 2023 at 04:30 PM.

Here’s what investors need to know about the announcement.

Earnings

F N B beat estimated earnings by 2.56%, reporting an EPS of $0.4 versus an estimate of $0.39.

Revenue was up $103.64 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 3.51% increase in the share price the next day.

Here’s a look at F N B’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.42 0.36 0.30 0.23
EPS Actual 0.44 0.39 0.31 0.26
Revenue Estimate 398.77M 363.74M 335.12M 312.30M
Revenue Actual 415.50M 379.59M 335.84M 312.40M

To track all earnings releases for F N B visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Celyad Oncology Q4 2022 Business Update And 2023 Outlook; As Of Dec 31, 2022, The Co. Ended The Year With An Unaudited Treasury Position Of $13.3M; Co. Is Now Prioritizing Discovery Endeavors To Tackle The Major Current Limitations Of CAR T-Cell Therap…

Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to one fully harnessing the true potential of its proprietary technology platforms and intellectual property The

CYAD